Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders

 
 

Foghorn Therapeutics Inc. Add to portfolio


Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18
Revenues19.21.30.40.021.2
            Revenue growth1357.8%206.7% -100.0% 
Cost of goods sold0.00.00.00.026.0
Gross profit19.21.30.40.0-4.8
            Gross margin100.0%100.0%100.0% -22.7%
Research and development105.680.357.744.4 
General and administrative30.721.711.26.74.8
EBIT-117.1-100.7-68.5-51.1-26.0
            EBIT margin-609.2%-7637.1%-15937.4% -122.7%
Pre-tax income-108.9-101.3-68.8-51.1-26.3
Income taxes0.00.00.00.00.0
            Tax rate0.0%0.0%0.0%0.0%0.0%
Net income-108.9-101.3-68.8-51.1-26.3
            Net margin-566.3%-7681.6%-16000.0% -124.1%
 
Diluted EPS($2.62)($2.73)($6.23)($12.20)($8.94)
Shares outstanding (diluted)41.637.211.04.22.9
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy